Werba Rubin Papier Wealth Management Raises Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Werba Rubin Papier Wealth Management raised its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 44.6% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,842 shares of the financial services provider’s stock after purchasing an additional 877 shares during the quarter. Werba Rubin Papier Wealth Management’s holdings in iShares Biotechnology ETF were worth $390,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of IBB. Future Financial Wealth Managment LLC acquired a new stake in shares of iShares Biotechnology ETF in the first quarter worth approximately $27,000. Bbjs Financial Advisors LLC acquired a new stake in iShares Biotechnology ETF during the 2nd quarter worth approximately $31,000. Pacifica Partners Inc. grew its stake in iShares Biotechnology ETF by 118.2% during the 1st quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock worth $33,000 after purchasing an additional 130 shares in the last quarter. Crewe Advisors LLC increased its stake in shares of iShares Biotechnology ETF by 42.9% during the fourth quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock worth $35,000 after buying an additional 78 shares during the period. Finally, YHB Investment Advisors Inc. purchased a new stake in shares of iShares Biotechnology ETF in the 1st quarter valued at approximately $37,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 1.4 %

Shares of IBB traded down $2.04 during mid-day trading on Friday, reaching $142.75. The company’s stock had a trading volume of 1,310,269 shares, compared to its average volume of 1,536,689. The company’s 50 day moving average is $144.12 and its 200 day moving average is $138.01. iShares Biotechnology ETF has a 12-month low of $111.83 and a 12-month high of $150.17.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.